Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

Autor: de Gramont, Aimery, Van Cutsem, Eric, Schmoll, Hans-Joachim, Tabernero, Josep, Clarke, Stephen, Moore, Malcolm J, Cunningham, David, Cartwright, Thomas H, Hecht, J Randolph, Rivera, Fernando, Im, Seock-Ah, Bodoky, György, Salazar, Ramon, Maindrault-Goebel, Frédérique, Shacham-Shmueli, Einat, Bajetta, Emilio, Makrutzki, Martina, Shang, Aijing, André, Thierry, Hoff, Paulo M
Zdroj: In Lancet Oncology December 2012 13(12):1225-1233
Databáze: ScienceDirect